Literature DB >> 10447407

Leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay.

S M Lipson.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10447407      PMCID： PMC85337     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  6 in total

1.  Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation.

Authors:  M Boeckh; R A Bowden; J M Goodrich; M Pettinger; J D Meyers
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

2.  Evaluation of a leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay.

Authors:  C E Bush; J A Sluchak-Carlsen
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test.

Authors:  K K Dodt; P H Jacobsen; B Hofmann; C Meyer; H J Kolmos; P Skinhøj; B Norrild; L Mathiesen
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

4.  The pp65 antigenaemia test as a predictor of cytomegalovirus-induced end-organ disease in patients with AIDS.

Authors:  D Francisci; A Tosti; F Baldelli; G Stagni; S Pauluzzi
Journal:  AIDS       Date:  1997-09       Impact factor: 4.177

5.  Application of a standardized cytomegalovirus antigenemia assay in the management of patients with AIDS.

Authors:  S M Lipson; M E Match; A I Toro; M H Kaplan; D H Shepp
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

6.  Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease.

Authors:  M L Landry; D Ferguson
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.